<?xml version="1.0" encoding="UTF-8"?>
<p id="Par84">Between December 2013 and November 2016, 10 consecutive patients were enrolled and followed up for a period of 12 months according to the study protocol. Baseline characteristics are presented in Table 
 <xref rid="Tab1" ref-type="table">1</xref>. All patients were males and the mean age was 69.4 ± 3.8 years. All patients had a history of coronary artery bypass grafting and seven patients experienced MI. Two patients were implantable cardioverter defibrillator (ICD) recipients and two patients had a spinal cord stimulator. Medications at baseline, including the use of long-lasting nitroglycerin and ranolazine to manage RA, are presented in Table 
 <xref rid="Tab1" ref-type="table">1</xref>.
</p>
